PNUFEXIV Trademark

Trademark Overview


On Wednesday, January 31, 2024, a trademark application was filed for PNUFEXIV with the United States Patent and Trademark Office. The USPTO has given the PNUFEXIV trademark a serial number of 98383876. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 15, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The PNUFEXIV trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
pnufexiv

General Information


Serial Number98383876
Word MarkPNUFEXIV
Filing DateWednesday, January 31, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2024

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 31, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Wednesday, January 31, 2024NEW APPLICATION ENTERED
Thursday, May 30, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 24, 2024NON-FINAL ACTION WRITTEN
Saturday, August 24, 2024ASSIGNED TO EXAMINER
Tuesday, August 27, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, August 24, 2024NON-FINAL ACTION E-MAILED
Saturday, August 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 27, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, August 27, 2024SUSPENSION LETTER WRITTEN
Tuesday, August 27, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, August 27, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 27, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, September 10, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 15, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024EXAMINERS AMENDMENT -WRITTEN